Browsing by Author SEIDL C.

Showing results 21 to 40 of 44 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2018JRC106081Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in RadiotherapyWURZER A; SEIDL C.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER MARKUS; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2018JRC112882Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: Towards improved alpha-therapeuticsŠIMEČEK JAKUB; HERMANN PETR; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2012JRC76583Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestVALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank, et alArticles in periodicals and books
2015JRC95224Fractionated intravesical radioimmunotherapy with 213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinomaFAZEL J; RÖTZER S; SEIDL C.; FEUERECKER Benedikt; AUTENRIETH Michael; WEIRICH G; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2005JRC30250Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal AntibodyBLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2012JRC64881High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumRAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2001JRC21246Highly Specific Tumor Binding of a 213Bi Labeled Monoclonal Antibody against Mutant E-Cadherin Suggests its Usefulness for Locoregional alpha-Radioimmunotherapy of Diffuse-Type Gastric Cancer.SENEKOWITSCH-SCHMIDTKE R.; SCHUHMACHER C.; BECKER K.; NIKULA T.k.; SEIDL C.; BECKER I.; MIEDERER M.; APOSTOLIDIS Christos; ADAM C.; HUBER Roswitha, et alArticles in periodicals and books
2017JRC104278Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-VersagenAUTENRIETH M.; HORN Thomas; KURTZ F; NGUYEN K; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SCHWAIGER M.; BLECHERT B.; SEIDL C.; SENEKOWITSCH-SCHMIDTKE R., et alArticles in periodicals and books
2007JRC38135Non-invasive Visualisation of the Development of Peritoneal Carcinomatosis and Tumour Regression After 213Bi-radioimmunotherapy Using Bioluminescence ImagingBUCHHORN H.m.; SEIDL C.; BECK R.; SAUR D.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2015JRC94668Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenograftsHESKAMP Sandra; HERNANDEZ Reinier; ESSLER Markus; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; OYEN Wim; SEIDL C.; MCBRIDE William; GOLDENBERG David; BOERMAN OttoArticles in periodicals and books
2009JRC55683Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2012JRC70296Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.Articles in periodicals and books
2019JRC116490The Response of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Cell Lines on Standard Therapy and Treatment with an Experimental Alpha-Particle Emitter Immunoconjugate Targeting EGFR (Bi-213- Cetuximab)SIEGL MICHAEL; SEIDL C.; PIONTEK GUIDO; WEBER WOLFGANG; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; MULTHOFF GABRIELE; PICKHARD ANJAArticles in periodicals and books
2019JRC113791Safety and efficacy of Ac-225-PSMA-617 in mCRPC after failure of Lu-177-PSMAFEUERECKER BENEDIKT; KNORR KARINA; BEHESHTI A; SEIDL C.; D'ALESSANDRIA C; BRUCHERTSEIFER FRANK; TAUBER R; RETZ M; WEBER WOLFGANG; MORGENSTERN ALFRED, et alArticles in periodicals and books
2019JRC116436Safety and efficacy of Ac-225-PSMA-617 in mCRPC after failure of Lu-177-PSMAFEUERECKER BENEDIKT; KNORR KARINA; BEHESHTI A; SEIDL C.; D'ALESSANDRIA C; BRUCHERTSEIFER FRANK; TAUBER R; RETZ M; WEBER WOLFGANG; MORGENSTERN ALFRED, et alArticles in periodicals and books
2014JRC88672Step forward with Bi-213: Cyclen-based phosphonates show improved radiolabeling and stabilityŠIMEČEK Jakub; HERMANN Petr; SEIDL C.; MORGENSTERN Alfred; NOTNI Johannes; BRUCHERTSEIFER Frank; WESTER Hans-JürgenArticles in periodicals and books
2012JRC68042Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C.Articles in periodicals and books
2009JRC55682Therapeutic efficacy of intravesical -radioimmunotherapy with Bi-213-anti-EGFR-MAb in a human bladder cancer nude mouse modelPFOST B.; SEIDL C.; AUTENRIETH M.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2013JRC79575Treatment of Bladder Cancer with Bi-213-anti-EGFR Immunoconjugates in a Nude Mouse ModelSEIDL C.; PFOST B.; MÜLLER Felix; RÖTZER S; FAZEL J; GILBERTZ K.-P.; FEUCHTINGER A; WEIRICH G; MORGENSTERN Alfred; BRUCHERTSEIFER Frank, et alArticles in periodicals and books
2014JRC88670Treatment of bladder cancer with Bi-213-anti-EGFR-MAb – a pilot studySCHEIDHAUER Klemens; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; AUTENRIETH Michael; KURTZ F; ESSLER M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books